Journal Mobile Options
Table of Contents
Vol. 35, No. 1, 1995
Issue release date: 1995
Add to my selection Citation Download
Eur Neurol 1995;35:43–45
(DOI:10.1159/000117088)
Original Paper

Treatment of Hemifacial Spasm with Botulinum Toxin

Value of Preinjection Electromyography Abnormalities for Predicting Postinjection Lower Facial Paresis Angibaud G.a · Moreau M.a · Rascol O.b · Clanet M.a
aService de Neurologie et d’Explorations Fonctionnelles Neurologiques, et bService de Pharmacologic Clinique, Hôpital Purpan, Toulouse, France Eur Neurol 1995;35:43–45 (DOI:10.1159/000117088)

Abstract

Thirty-two patients with hemifacial spasm were treated with 61 botulinum toxin (BT) injections. Some patients had post-BT lower facial paresis (LFP+ group) while others did not suffer this side effect (LFP- group). Abnormal electromyography (EMG) recordings were more frequent in the LFP+ group (6/11) than in the LFP- group (3/21; p < 0.05). This result suggests that an EMG performed before any BT injection could detect the patients with a higher risk for this side effect. The first dose of BT might be lowered in such cases.

 goto top of outline Author Contacts

Olivier Rascol, Service de Pharmacologic Clinique, Hôpital Purpan, Place du Dr Baylac, F-31059 Toulouse Cedex (France)


 goto top of outline Article Information

Received: October 20, 1993
Accepted: March 9, 1994
Published online: February 12, 2008
Number of Print Pages : 3


 goto top of outline Publication Details

European Neurology

Vol. 35, No. 1, Year 1995 (Cover Date: 1995)

Journal Editor: Bogousslavsky, J. (Montreux)
ISSN: 0014–3022 (Print), eISSN: 1421–9913 (Online)

For additional information: http://www.karger.com/ENE


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.